Pulmonary Hypertension (PH) Completed Phase 2 Trials for Macitentan (DB08932)

Also known as: Pulmonary; Hypertension / Hypertension Pulmonary / Hypertension, Pulmonary / Pulmonary hypertensions / Pulmonary Hypertension / Other secondary pulmonary hypertension / Pulmonary hypertension NOS

IndicationStatusPhase
DBCOND0051788 (Pulmonary Hypertension (PH))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02651272Macitentan in Pulmonary Hypertension of Sickle Cell DiseaseOther
NCT02070991Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular DysfunctionTreatment